首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1427732

2024 年肉毒毒素全球市場報告

Botulinum Toxin Global Market Report 2024

出版日期: 按訂單生產 | 出版商:

The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

肉毒桿菌毒素市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 9.2% 的年複合成長率（CAGR）成長至 105.3 億美元。預測期內的預期成長歸因於多種因素，包括美容醫學市場的擴大、配方和給藥方法的進步、治療應用的多樣化、世界老齡化、新興市場需求的增加以及患者數量的增加。這可歸因於重要因素。認可和接受以及全球市場的整體擴張。這些因素預計將推動肉毒桿菌應用的持續成長。預測期內預計的主要趨勢包括行業內的策略聯盟、個人化精準醫療方法的採用、新適應症的監管核准以及持續的產品創新。這些趨勢反映了肉毒桿菌應用不斷發展的形勢，重點是提高治療功效、安全性並滿足更廣泛的醫療和美容需求。

預計對美容手術的需求不斷成長將在可預見的未來顯著推動肉毒桿菌毒素市場的擴張。美容手術包括旨在透過手術或非手術手段改善個人外觀的各種美容手術。這些手術中常用的肉毒桿菌毒素可有效放鬆某些肌肉並減少皺紋和細紋的出現。例如，根據美國美容整形外科學會發布的2021年美容整形外科統計報告，該領域的手術活動顯著增加。比較2020年（220例）和2021年（320例）整形外科醫師的平均手術數量，突顯出顯著的成長，顯示美容治療的需求穩定成長。因此，對美容手術不斷成長的需求已成為肉毒桿菌毒素市場成長的驅動力。

世界人口老化的迅速成長預計將在未來幾年推動肉毒桿菌市場的擴張。「人口老化」一詞是指以社會中老年人比例不斷增加為特徵的人口變化。肉毒桿菌毒素是一種廣受老年人歡迎的微創治療皺紋和細紋的方法，是一種非手術的美容方式，可以讓您的容貌變得更年輕，我們將為您提供方法所以。根據世界衛生組織 (WHO) 2022 年 10 月報告，全球 60 歲以上人口正處於快速成長軌道，預計到 2050 年將加倍，達到約 21 億。這種人口結構向老化的轉變將極大地促進肉毒桿菌毒素治療需求的增加，從而推動肉毒桿菌市場的成長。

全球肉毒桿菌毒素市場，按類型細分、實際和預測，2018-2023、2023-2028、2033
A型肉毒桿菌毒素
B型肉毒桿菌
全球肉毒桿菌毒素市場，按應用細分、實際和預測，2018-2023、2023-2028、2033
治療
美麗
全球肉毒桿菌毒素市場，依最終用戶細分，實際與預測，2018-2023、2023-2028、2033
醫院
專科診所
皮膚科診所
其他最終用戶

第 7 章區域與國家分析

全球肉毒桿菌毒素市場、地區、績效與預測，2018-2023、2023-2028、2033
全球肉毒桿菌毒素市場，依國家、實際及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭形勢及公司概況

肉毒毒素市場競爭形勢
肉毒桿菌毒素市場公司概況
- Cigna Group
- Pfizer Inc.
- AbbVie Inc.
- Teijin Pharma Ltd.
- Eisai Co. Ltd.

第31章其他大型創新公司

Menarinin Group
Ipsen Group
Galderma SA
Daewoong Pharmaceuticals Co. Ltd.
Supernus Pharmaceuticals Inc.
Merz Pharma GmbH &Co. KGaA
Hugel Inc.
Evolus Inc.
Medytox Inc.
Revance Therapeutics Inc.
Sinclair Pharma
US WorldMeds LLC
Hugh Source International Ltd.
MedivaPharma
Wigmore Medical

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章重大併購

第35章未來前景與可能性分析

第36章附錄

簡介目錄

Product Code: r13576

Botulinum toxin, commonly known as Botox, is a neurotoxic protein produced by the bacterium Clostridium botulinum, recognized as one of the most potent toxins known to humans. Its applications span both medical and cosmetic purposes, encompassing the treatment of muscle spasms, reduction of wrinkles, management of excessive sweating, and addressing specific eye and bladder disorders.

The primary types of botulinum toxins include botulinum toxin type A and botulinum toxin type B. Botulinum toxin type A is a neurotoxic protein produced by Clostridium botulinum, widely utilized in various medical and cosmetic procedures. These applications extend to both therapeutic and aesthetic uses, with diverse end-users such as hospitals, specialty clinics, dermatology clinics, and others.

The botulinum toxins market research report is one of a series of new reports from The Business Research Company that provides botulinum toxins market statistics, including botulinum toxins industry global market size, regional shares, competitors with a botulinum toxins market share, detailed botulinum toxins market segments, market trends, and opportunities, and any further data you may need to thrive in the botulinum toxins industry. This botulinum toxins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The botulinum toxin market size has grown rapidly in recent years. It will grow from $6.72 billion in 2023 to $7.4 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth observed during the historical period can be attributed to various factors, including the widespread adoption of botulinum toxin for cosmetic applications, its utilization in various medical therapies, the expansion of the field of aesthetic medicine, increased awareness and acceptance of these treatments, and ongoing research and development initiatives. These factors collectively contributed to the historical growth of botulinum toxin applications in both cosmetic and medical settings.

The botulinum toxin market size is expected to see strong growth in the next few years. It will grow to $10.53 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The anticipated growth in the forecast period can be attributed to several key factors, including the expansion of the aesthetic medicine market, advancements in formulations and delivery methods, the diversification of therapeutic applications, the global aging population, increasing demand in emerging markets, growing patient awareness and acceptance, and overall global market expansion. These factors are expected to drive the continued growth of botulinum toxin applications. Major trends expected in the forecast period include strategic collaborations within the industry, the adoption of personalized and precision medicine approaches, regulatory approvals for new indications, and ongoing product innovations. These trends reflect the evolving landscape of botulinum toxin applications, with a focus on enhancing therapeutic efficacy, safety, and addressing a broader range of medical and cosmetic needs.

The escalating demand for aesthetic procedures is projected to significantly boost the expansion of the botulinum toxin market in the foreseeable future. Aesthetic procedures encompass various cosmetic treatments aimed at refining an individual's appearance, whether through surgical or non-surgical means. Botulinum toxin, commonly utilized in these procedures, effectively relaxes specific muscles, diminishing the visibility of wrinkles and fine lines. For instance, as per the Aesthetic Plastic Surgery statistical report published by The American Society for Aesthetic Plastic Surgery in 2021, there was a substantial surge in surgical activity within the field. Comparing the average number of surgical procedures performed by plastic surgeons in 2020 (220 procedures) to 2021 (320 procedures) highlights a noteworthy increase, signaling a robust uptick in demand for aesthetic treatments. Consequently, the heightened demand for aesthetic procedures emerges as a driving force behind the growth of the botulinum toxin market.

The burgeoning global aging population is anticipated to propel the expansion of the botulinum toxin market in the coming years. The term 'aging population' refers to a demographic shift characterized by a growing proportion of elderly individuals within a society. Botulinum toxin stands out as a popular and minimally invasive solution widely embraced by the aging population to address wrinkles and fine lines, offering a non-surgical avenue to enhance facial aesthetics and attain a more youthful appearance. As reported by the World Health Organization (WHO) in October 2022, the worldwide population aged 60 years and older is on a rapid growth trajectory, projected to double by 2050, reaching an estimated 2.1 billion individuals. This demographic shift towards an increasingly elderly population significantly contributes to the rising demand for botulinum toxin procedures, thereby propelling the growth of the botulinum toxin market.

Product innovation stands out as a prominent trend driving advancements in the botulinum toxin market, with companies actively pursuing innovative solutions to maintain their market positions. An illustration of this trend is evident in the developments by Evolus Inc., a US-based medical aesthetics company, which obtained approval from the Australian Therapeutic Goods Administration (TGA) in January 2023 for Nuceiva (prabotulinumtoxin A) in Australia. Nuceiva, containing botulinum toxin type A, is specifically designed for aesthetic purposes, aimed at temporarily enhancing the appearance of moderate glabellar lines in adult patients. The product functions by interrupting nerve impulses within facial muscles, inducing relaxation, and effectively smoothing wrinkles resulting from facial expressions such as squinting and frowning.

Major players in the botulinum toxin market are focusing on groundbreaking product innovations, exemplified by the introduction of robotic syringes, to offer customers enhanced and reliable services. One such instance is showcased by Juvaplus SA, a Switzerland-based provider, which launched Juvapen Expert for botulinum toxin in August 2021. The Juvapen Expert integrates the precision and control of a robotic arm with traditional syringe functionality. The technology facilitates precise toxin delivery in minute doses, as low as 0.005ml, reducing the likelihood of over- or under-injection. The automated process also contributes to expedited injection times, improving efficiency for both practitioners and patients. Additionally, the robotic delivery mechanism mitigates risks associated with manual injections, such as needle sticks and tissue damage, enhancing overall safety during the procedure.

In August 2021, Merz Pharma GmbH & Co. KGaA, a pharmaceutical company based in Germany, entered into a collaboration with Vensica Therapeutics Ltd. The collaboration aimed to explore the administration of botulinum neurotoxin-A (Xeomin) to the bladder wall utilizing Vensica's innovative ultrasound-assisted administration catheter. Vensica Therapeutics Ltd., headquartered in Israel, is a company specializing in the design and development of urology catheters and medication delivery systems. This collaboration represented a strategic partnership between the two companies to advance the delivery methods of botulinum neurotoxin-A for potential therapeutic applications in urology.

Major companies operating in the botulinum toxin market report are Cigna Group, Pfizer Inc., AbbVie Inc., Teijin Pharma Ltd., Eisai Co. Ltd., Menarinin Group, Ipsen Group, Galderma S.A., Daewoong Pharmaceuticals Co. Ltd., Supernus Pharmaceuticals Inc., Merz Pharma GmbH & Co. KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Revance Therapeutics Inc., Sinclair Pharma, US WorldMeds LLC, Hugh Source International Ltd., MedivaPharma, Wigmore Medical, AesthetiCare, Lanzhou Institute of Biological Products Co Ltd., AestheticSource, Botox Cosmetic, Metabiologics Inc.

North America was the largest region in the botulinum toxin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the botulinum toxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the botulinum toxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The botulinum toxin market consists of sales of botulinum toxin C and botulinum toxin D and their related formulations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Botulinum Toxin Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on botulinum toxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for botulinum toxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The botulinum toxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Type: Botulinum Toxin Type A; Botulinum Toxin Type B
2) By Application: Therapeutics; Aesthetics
3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
Companies Mentioned: Cigna Group; Pfizer Inc.; AbbVie Inc.; Teijin Pharma Ltd.; Eisai Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Botulinum Toxin Market Characteristics

3. Botulinum Toxin Market Trends And Strategies

4. Botulinum Toxin Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Botulinum Toxin Market Size and Growth

5.1. Global Botulinum Toxin Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Botulinum Toxin Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Botulinum Toxin Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Botulinum Toxin Market Segmentation

6.1. Global Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Botulinum Toxin Type A
Botulinum Toxin Type B
6.2. Global Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Therapeutics
Aesthetics
6.3. Global Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics
Dermatology Clinics
Other End Users

7. Botulinum Toxin Market Regional And Country Analysis

7.1. Global Botulinum Toxin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Botulinum Toxin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Botulinum Toxin Market

8.1. Asia-Pacific Botulinum Toxin Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Botulinum Toxin Market

9.1. China Botulinum Toxin Market Overview
9.2. China Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Botulinum Toxin Market

10.1. India Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Botulinum Toxin Market

11.1. Japan Botulinum Toxin Market Overview
11.2. Japan Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Botulinum Toxin Market

12.1. Australia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Botulinum Toxin Market

13.1. Indonesia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Botulinum Toxin Market

14.1. South Korea Botulinum Toxin Market Overview
14.2. South Korea Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Botulinum Toxin Market

15.1. Western Europe Botulinum Toxin Market Overview
15.2. Western Europe Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Botulinum Toxin Market

16.1. UK Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Botulinum Toxin Market

17.1. Germany Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Botulinum Toxin Market

18.1. France Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Botulinum Toxin Market

19.1. Italy Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Botulinum Toxin Market

20.1. Spain Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Botulinum Toxin Market

21.1. Eastern Europe Botulinum Toxin Market Overview
21.2. Eastern Europe Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Botulinum Toxin Market

22.1. Russia Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Botulinum Toxin Market

23.1. North America Botulinum Toxin Market Overview
23.2. North America Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Botulinum Toxin Market

24.1. USA Botulinum Toxin Market Overview
24.2. USA Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Botulinum Toxin Market

25.1. Canada Botulinum Toxin Market Overview
25.2. Canada Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Botulinum Toxin Market

26.1. South America Botulinum Toxin Market Overview
26.2. South America Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Botulinum Toxin Market

27.1. Brazil Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Botulinum Toxin Market

28.1. Middle East Botulinum Toxin Market Overview
28.2. Middle East Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Botulinum Toxin Market

29.1. Africa Botulinum Toxin Market Overview
29.2. Africa Botulinum Toxin Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Botulinum Toxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Botulinum Toxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Botulinum Toxin Market Competitive Landscape And Company Profiles

30.1. Botulinum Toxin Market Competitive Landscape
30.2. Botulinum Toxin Market Company Profiles
- 30.2.1. Cigna Group
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Pfizer Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. AbbVie Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Teijin Pharma Ltd.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Eisai Co. Ltd.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Botulinum Toxin Market Other Major And Innovative Companies

31.1. Menarinin Group
31.2. Ipsen Group
31.3. Galderma S.A.
31.4. Daewoong Pharmaceuticals Co. Ltd.
31.5. Supernus Pharmaceuticals Inc.
31.6. Merz Pharma GmbH & Co. KGaA
31.7. Hugel Inc.
31.8. Evolus Inc.
31.9. Medytox Inc.
31.10. Revance Therapeutics Inc.
31.11. Sinclair Pharma
31.12. US WorldMeds LLC
31.13. Hugh Source International Ltd.
31.14. MedivaPharma
31.15. Wigmore Medical

32. Global Botulinum Toxin Market Competitive Benchmarking

33. Global Botulinum Toxin Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Botulinum Toxin Market

35. Botulinum Toxin Market Future Outlook and Potential Analysis

35.1 Botulinum Toxin Market In 2028 - Countries Offering Most New Opportunities
35.2 Botulinum Toxin Market In 2028 - Segments Offering Most New Opportunities
35.3 Botulinum Toxin Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies